Rayonier Advanced Materials (RYAM) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Q1 2025 net sales were $356 million, down 8% year-over-year, with a net loss of $32 million, driven by lower volumes, higher input costs, operational setbacks, and a $12 million non-cash environmental charge.
Adjusted EBITDA was $17 million, down $35 million year-over-year, and adjusted free cash flow improved to $10 million.
Approximately $85 million in annual revenue is exposed to a 125% Chinese import tariff, with mitigation efforts focused on market diversification and operational adjustments.
Segment reorganization completed, now reporting five operating segments; strategic investments in biomaterials and green capital continue.
Liquidity remains solid at $272 million, with net secured debt at $624 million and a net secured leverage ratio of 2.9x covenant EBITDA.
Financial highlights
Gross margin for Q1 2025 was $24 million (6.7%), down from $37 million (9.5%) in Q1 2024; operating loss was $15 million, a $32 million decline year-over-year.
Adjusted EBITDA margin for Q1 2025 was 4.8%.
Cash provided by operating activities was $40 million; cash and equivalents stood at $130 million at quarter-end.
Total debt at quarter-end was $736 million; debt-to-capital ratio was 52%.
Maintenance CapEx was $30 million; strategic CapEx was $8 million in Q1 2025.
Outlook and guidance
2025 adjusted EBITDA guidance is $175–$185 million; adjusted free cash flow guidance is $5–$15 million.
Tariff-related impacts expected to reduce adjusted EBITDA by $20 million; Q1 production issues and $12 million non-cash environmental charge included in guidance.
Cellulose Specialties prices expected to rise mid-single digits, but volumes to decline due to tariffs and destocking; Paperboard volumes to increase but prices to decline.
High-Yield Pulp prices and volumes projected to fall due to oversupply in China; corporate costs higher in 2025 due to environmental charges and FX headwinds.
Maintenance capex at $85 million; cash interest expense projected at $93 million.
Latest events from Rayonier Advanced Materials
- Q1 2026 posted $319M sales, $81M net loss, $8M EBITDA, and positive free cash flow.RYAM
Q1 20266 May 2026 - Director nominee resigned; votes for this nominee won't count, all other matters unchanged.RYAM
Proxy filing24 Apr 2026 - Board refresh, executive pay alignment, and governance reforms headline this year's proxy.RYAM
Proxy filing30 Mar 2026 - Key votes include board declassification, supermajority removal, and executive pay approval.RYAM
Proxy filing30 Mar 2026 - Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026